Introduction {#sec1-1}
============

Complete androgen insensitivity syndrome (CAIS) is caused by an X-linked androgen receptor (AR) mutation that results in a female phenotype of external genitalia and appearance, but testes as the gonads instead of ovaries. This disease results from the lack of interaction between the mutated AR and testosterone; due to this, testosterone cannot induce any effect in cells expressing AR. Patients with CAIS also do not have a uterus. The testes are at a higher risk of malignant tumor and are usually surgically removed.

Anti-Müllerian hormone (AMH) is secreted by Sertoli cells and plays a role in the regression of Müllerian ducts during perinatal periods in the male.[@ref1] This effect lasts only during fetal testicular genesis. During the growth of a normal male, the serum AMH level is highest during the 1^st^ year of life, slightly decreases 1 year after birth, and decreases progressively to 3--4% of infant level after puberty.[@ref2] AMH level is affected by an increase in testosterone levels, and AR expression in Sertoli cells is vital to AMH downregulation after puberty.[@ref3] Few previous studies have shown that serum AMH level is very high in patients with CAIS or other conditions such as hypogonadotropic hypogonadism (Kallmann syndrome) that are associated with low testicular testosterone levels.

We experienced cases of two sisters with CAIS, and examined the serum level of AMH before and after laparoscopic gonadectomy (testicles). We examined the pathological status of CAIS and AMH levels before and after gonadectomy.

Case Reports {#sec1-2}
============

The patients were two sisters. The patients' mother had three daughters and two sons in total. All three sisters had primary amenorrhea.

Case 1 {#sec2-1}
------

A 43-year-old woman visited our hospital with the complaint of primary amenorrhea. Her height was 161 cm, weight 48 kg, and body mass index 18.9 kg/m^2^. Her external appearance was that of a female; a uterus was not detected, and she had a blind-ending vagina. Neither the ovaries nor the uterus were detected on magnetic resonance imaging; however, testes were detected inside the pelvis. Karyotyping revealed a 46 XY karyotype. Her serum luteinizing hormone (LH) level was 44.2 mIU/mL and follicular-stimulating hormone (FSH) level was 37.4 mIU/mL, which were extremely high compared with the levels in a normal adult man. Other hormone levels are presented in [Figure 1](#F1){ref-type="fig"}. LH, FSH, total testosterone, and estradiol levels were measured using a competitive immunoassay with the use of an electrochemiluminescence immunoassay (ECLIA; Roche Diagnostics GmbH, Mannheim, Germany). The reference values of these serum hormone levels were 2.2--8.4 mIU/mL for LH, 1.8--12 mIU/mL for FSH, 1.31--8.71 ng/mL for total testosterone, and 14.6--48.8 pg/mL for estradiol, according to the manufacturers' directions. The diagnosis of CAIS was confirmed.

![Serum gonadal hormone levels. (A) Anti-Müllerian hormone (AMH), (B) total testosterone, and (C) estradiol decreased drastically after operation.](GMIT-6-126-g001){#F1}

Prophylactic laparoscopic gonadectomy was performed ([Figure 2](#F2){ref-type="fig"}). The operation time was 35 minutes and blood loss was very small. She was discharged from hospital 2 days after surgery. Pathological examination revealed immature testes and no testicular malignancy. Her serum AMH level, as assessed using an enzyme-linked immunosorbent assay (AMH Gen II ELISA; Beckman Coulter, Inc., California, USA), was extremely high before the surgery; however, AMH and other gonadal hormone levels decreased dramatically after the surgery compared to those before ([Figure 1](#F1){ref-type="fig"}). After 1.5 years from surgery, AMH level decreased to \<0.1 ng/mL.

![Laparoscopic gonadectomy. (A) Intraoperative image of bilateral gonads; (B) resection of the right gonad; (C) resection of the left gonad; and (D) pelvic image after gonadectomy.](GMIT-6-126-g002){#F2}

Case 2 {#sec2-2}
------

The patient, aged 41 years, the sister of the previously described patient, presented to our hospital for gonadectomy as per her sister's recommendation. Her height was 161cm, weight was 48 kg, and body mass index was 18.5 kg/m^2^. Her diagnostic evaluation was the same as that of her sister. Her serum LH level was 78.3 mIU/mL and FSH level was 59.3 mIU/mL, which were as high as those of her sister. She had a history of inguinal hernia surgery. She also underwent laparoscopic gonadectomy. Her operation time was 29 minutes, and her perioperative period was similar to that of her sister. The gonads had no malignancy by pathological examination. Her gonadal hormone levels are also shown in [Figure 1](#F1){ref-type="fig"}. Three months after surgery, her AMH level decreased to below measurable limits (\<0.1 ng/mL).

Discussion {#sec1-3}
==========

Patients with CAIS have a female phenotype. However, such patients have a 46XY karyotype and the gonads (testes) are inside their pelvis or inguinal canal. Gonads (testes) in the case of abnormal sex differentiation have a risk of malignant tumor. The risk is known to increase with age and depends on the type of Y-chromosome sex differentiation disorder. The risk of malignancy was reported at about 5% and may be less in CAIS than in partial AIS.[@ref4][@ref5] Risk of gonadal malignancy is reported to increase up to 14% (0--22%) after puberty, reaching up to 33% at the age of 50 years.[@ref6][@ref7] Laparoscopic gonadectomy is a well-tolerated method of excision of gonads.[@ref8] However, estrogen replacement therapy (ERT) is essential after surgery, as increased estradiol levels are necessary for the development of secondary sexual characteristics. Prophylactic gonadectomy after puberty can be recommended after considering the risks and benefits, because ERT is more difficult during puberty. In both cases, laparoscopic gonadectomy was performed and ERT was started after their surgeries. Surgery in our cases was delayed because of their apprehension toward surgery and lack of knowledge of the risks of gonadal malignancy until the visit to our hospital. Hence, providing accurate information to patients is critical.

Sertoli cells secrete AMH, which causes regression of Müllerian ducts during the development of fetal gonads and male reproductive organs. Testosterone interacts with AR in Sertoli cells to repress AMH secretion and to contribute to germ cell maturation. AMH levels are very high in male infants because of the absence of functional AR in Sertoli cells.[@ref2] The median serum AMH level reportedly decreases from about 150 ng/mL in male infants aged 3 months to 6 ng/mL in adult men (18--69 years old). The serum AMH level increases abnormally in children with CAIS and remains extremely high even after puberty in those with CAIS because of the lack of functional AR.[@ref3][@ref9] Both the patients had elevated AMH levels. In both cases, we measured AMH levels before and after gonadectomy. The half-life value of AMH was measured at 3.37 days in Case 1 and 2.08 days in Case 2. The approximate estimated half-life value is 3 days. Serum AMH level rapidly decreased after gonadectomy, as did other gonadal hormone levels (testosterone and estradiol). Currently, serum AMH level is easily measured on a commercial basis. This should be helpful in the differential diagnosis of AIS and abnormal sex differentiation. Although successful gonadectomy can be proven only by measuring the levels of testosterone and estradiol, AMH levels can aid in confirmation. Although some testosterone is secreted by adrenal glands and aromatized to estradiol, AMH is secreted only by Sertoli cells. Decrease of AMH levels to below measurable levels indicates successful gonadectomy. In both cases, serum AMH level was \<0.1 ng/mL after gonadectomy.

Prophylactic gonadectomy should be performed after puberty as a minimally invasive laparoscopic surgery. Our report indicates that serum AMH level is useful in the diagnosis and follow-up of CAIS.
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